Technoscience is in fact part of the Invitalia Startup System, the national network promoted by Invitalia to connect the key players in Italy’s innovation ecosystem. This strategic relationship enables startups and innovative projects to gain access to expertise, networking opportunities, financial instruments and tailored growth support programmes.
“Research generates economic value when it can be translated into businesses, investment and highly skilled employment,” says Lorenzo Sgarro, Chartered Accountant and member of Technoscience’s Board of Directors. “Our relationship with Invitalia enables us to connect innovative projects with the tools and opportunities they need to grow. The goal is to foster strong companies capable of attracting capital and competing in the market.”
It is within this context that the International Biotech Academy is taking shape, designed to connect the scientific community, businesses, professionals, investors and institutions, while developing new skills and expertise in the biotech and Life Sciences sectors.
“The Biotech Academy was created to connect advanced education, research and technology transfer with the real needs of businesses,” explains Stefano Di Rosa, General Manager of Technoscience. “Investing in skills means strengthening the ability to turn scientific knowledge into patents, startups, products and new development opportunities.”
The Rome Future Week thus becomes the setting for a broader strategy in which Technoscience aims to act as a bridge between research and the market, while its relationship with Invitalia strengthens its ability to guide innovation towards the right tools, capital and growth pathways.
The project is further enriched by the contribution of Prof. Felice Paolo Arcuri, CEO and co-founder of S3 Opus and adjunct professor at the University of Rome Tor Vergata, and Roberto Panzarani, President of Panzarani & Associates and lecturer in Innovation Management, both of whom have long been engaged in the fields of education, organisational innovation, skills development and the creation of innovation ecosystems.
The challenge of the International Biotech Academy is therefore clear: to develop skills, enhance the value of research and create the conditions for innovation to translate into business and economic development.
How we turn ideas into biotech projects
Would you like to understand how we could work together on complex biotech projects, such as the one on glioblastoma? Below is a selection of in-depth pages on biopharmaceutical pipelines, biobanks, data management and AI, telemedicine, precision cardiology and TRL pathways. They are the starting point for turning a good idea into an operational pathway, from the initial concept through to clinical validation and market entry.
Careers & Skills
Industry & Technology Transfer
GREEN & AGRI-BIOTECH
Biopharmaceuticals & Therapies
Biotechnology for Health
Frequently Asked Questions
Biotech FAQ
The questions you ask us most often
It is an approach that defines the the actual biology of the disease (tissues, markers and omics profiles where indicated) and links it to diagnostic and therapeutic decisions diagnostic and therapeutic personalised. It does not stop at generic classifications or guidelines applied wholesale: it builds a individual pathway measurable through robust clinical endpoints.
An enabling role. The biobanks ensure traceable and comparable samples; the omics broaden the understanding of the underlying mechanisms (inflammatory, metabolic and genetic). When integrated with rigorous protocols and real-world data, make reproducible the evidence and accelerate translation towards clinical trials or clinical adoption.
